繁
简
Market+ (iPhone)
Market+ (Android)
Mobile Site
US STOCKS
FUNDS
FX & CRYPTO
SH/SZ-HK
HK STOCKS
 
 
 
 
 
 
Quote Service
Market
Market
Quotes
Quotes
Analysis
Analysis
Commentary
Commentary
Warrants&CBBCs
Warrants&CBBCs
Warrants&CBBCs Overview
Warrants
CBBCs
ETF
ETF
MPF
MPF
Education
Members
Members
About Us
About Us

ETF Overview

TRACKER FUND
ISHARES A50
HSCEI ETF
CSOP A50 ETF
CAM CSI300
Last (HKD)1
Details»
Vol. 
Turn. 
Range
NAV (HKD)
Premium%
1-Month Range
2-Month Range
3-Month Range
52-Week Range
1D
1M
Advanced Chart
ETF Overview
Issuer
Expenses & Facts
Analysis
Calendar Yr Chg
Cumulative Chg
Overview (By Turn.)
Overview (By Asset)
Name/ Symbol
Underlying Asset
Last1
Chg
Chg%
Vol.
Turn.
NAV (Premium%)
Chart
Compare
TRACKER FUND
 Hang Seng Index 25.540
 HKD 		+0.460 +1.834% 826.39M 21.17B 25.077 (+1.846%)
HKD as at 2026/03/31
HSCEI ETF
 Hang Seng China Enterprises Index 86.900
 HKD 		+1.380 +1.614% 120.24M 10.49B 85.732 (+1.362%)
HKD as at 2026/03/31
CSOP HS TECH
 Hang Seng TECH Index 4.646
 HKD 		+0.096 +2.110% 2.07B 9.59B 4.546 (+2.197%)
HKD as at 2026/03/31
XL2CSOPHYNIX
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
 SK hynix Inc. 24.000
 HKD 		+3.680 +18.110% 127.05M 3.03B 20.028 (+19.833%)
HKD as at 2026/03/31
XL2CSOPHSTECH
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
 Hang Seng TECH Index 3.630
 HKD 		+0.152 +4.370% 347.78M 1.26B 3.489 (+4.032%)
HKD as at 2026/03/31
XL2CSOPSMSN
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
 Samsung Electronics Co Ltd 69.140
 HKD 		+14.080 +25.572% 12.72M 859.20M 55.435 (+24.722%)
HKD as at 2026/03/31
XI2CSOPHSTECH
-2x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
 Hang Seng TECH Index 1.838
 HKD 		-0.082 -4.271% 316.54M 581.79M 1.920 (-4.251%)
HKD as at 2026/03/31
FI2 CSOP HSI
-2x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
 Hang Seng Index 1.820
 HKD 		-0.072 -3.805% 211.74M 383.09M 1.897 (-4.039%)
HKD as at 2026/03/31
FL2 CSOP HSI
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
 Hang Seng Index 5.590
 HKD 		+0.210 +3.903% 57.74M 324.52M 5.374 (+4.029%)
HKD as at 2026/03/31
SPDR GOLD TRT
 London Gold Fixing Price 3,393.000
 HKD 		+105.000 +3.193% 81.45K 276.21M 416.060 (+4.056%)
USD as at 2026/03/30
A GX HSCEICC
 9.450
 HKD 		+0.080 +0.854% 29.06M 275.22M 9.364 (+0.923%)
HKD as at 2026/03/31
ISHARESHSTECH
 Hang Seng TECH Index (net total return version) 9.970
 HKD 		+0.180 +1.839% 27.08M 269.77M 9.752 (+2.232%)
HKD as at 2026/03/31
A CSOP HSCEICC
 8.025
 HKD 		+0.065 +0.817% 22.44M 180.65M 7.959 (+0.829%)
HKD as at 2026/03/31
CAM HSBIOTECH
 Hang Seng Biotech Index 15.590
 HKD 		+0.930 +6.344% 11.04M 169.65M 14.639 (+6.500%)
HKD as at 2026/03/31
HS HIGH DIV
 Hang Seng High Dividend 30 Index (price return version) 20.660
 HKD 		+0.310 +1.523% 6.40M 132.58M 20.419 (+1.183%)
HKD as at 2026/03/31
HSTECH ETF
 Hang Seng TECH Index 4.728
 HKD 		+0.104 +2.249% 26.76M 126.39M 4.626 (+2.198%)
HKD as at 2026/03/31
FL2CSOPGOLD
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
 Solactive Gold 1-Day Rolling Futures Index 29.500
 HKD 		+1.800 +6.498% 3.84M 112.59M 28.655 (+2.951%)
HKD as at 2026/03/31
CAM CSI300
 CSI 300 Index 53.100
 HKD 		+0.320 +0.606% 1.15M 61.17M 52.333 (+1.466%)
HKD as at 2026/03/31
CAM HSI ESG
 HSI ESG Enhanced Index 51.440
 HKD 		+1.080 +2.145% 1.16M 59.80M 50.333 (+2.200%)
HKD as at 2026/03/31
A GX HSTCC
 7.800
 HKD 		+0.105 +1.365% 6.37M 49.64M 7.841 (-0.524%)
HKD as at 2026/03/30
FI2CSOPNASDAQ
-2x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
 NASDAQ-100 Index 3.636
 HKD 		-0.236 -6.095% 13.47M 49.10M 3.687 (-1.383%)
HKD as at 2026/03/31
F SAMSUNG OIL
 S&P GSCI Crude Oil Multiple Contract 55/30/15 1M/2M/3M (USD) ER Index 9.710
 HKD 		-0.610 -5.911% 4.98M 49.09M 10.365 (-6.322%)
HKD as at 2026/03/30
F GX OIL
 S&P GSCI Crude Oil Enhanced Index Excess Return 8.000
 HKD 		-0.300 -3.614% 5.70M 46.13M 8.356 (-4.262%)
HKD as at 2026/03/30
INVESCO QQQ
 NASDAQ-100 Index 4,562.000
 HKD 		+139.000 +3.143% 10.09K 46.06M 558.290 (+4.265%)
USD as at 2026/03/30
FL2 CSOP HSCEI
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
 Hang Seng China Enterprises Index 2.970
 HKD 		+0.088 +3.053% 10.99M 32.88M 2.879 (+3.150%)
HKD as at 2026/03/31
ISHARES A50
 FTSE China A50 Index 16.150
 HKD 		+0.200 +1.254% 1.99M 32.26M 15.925 (+1.414%)
HKD as at 2026/03/31
CSOP HK EQUITY
 FTSE MPF Hong Kong Index 9.170
 HKD 		+0.245 +2.745% 3.41M 31.31M 8.934 (+2.645%)
HKD as at 2026/03/31
FI2 CSOP NIKKEI
-2x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
 Nikkei Stock Average 23.720
 HKD 		-2.180 -8.417% 1.30M 31.23M 26.321 (-9.881%)
HKD as at 2026/03/31
XI2CSOPSMSN
-2x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
 Samsung Electronics Co Ltd 0.289
 HKD 		-0.094 -24.543% 95.09M 28.39M 0.386 (-25.207%)
HKD as at 2026/03/31
GX HS HIGHDIV
 Hang Seng High Dividend Yield Index 32.000
 HKD 		+0.460 +1.458% 833.44K 26.72M 31.541 (+1.455%)
HKD as at 2026/03/31
(1) All quotes for Hong Kong Stocks are at least 15 minutes delayed. Last Updated: 2026/04/01 16:08
 
SITEMAP
AASTOCKS.com
 
 
Members
 
About Us
Market
Quotes
 
Analysis
News & Research
 
Commentary
 
Warrants&CBBCs
 
Warrants
 
CBBCs
 
US Stocks
Forex
 
Fund
 
MPF
Email: support@aastocks.com
AASTOCKS.COM LIMITED (阿斯達克網絡信息有限公司) All rights reserved.
Disclaimer
AASTOCKS.COM LIMITED (阿斯達克網絡信息有限公司), HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

The above is strictly for information purposes only and should not be considered an offer, or solicitation, to deal in any of the mentioned funds. Investment involves risk, emerging markets may have greater risk than developed markets. Subscriptions may only be made on the basis of the relevant offering documents, most recent annual financial statement and semi-annual financial statements if published thereafter. The value of investments and the income received from them (if any) may be volatile and could change substantially within a short period of time. Past performance is not a guide to future performance. The investment returns are denominated in the base currency of the fund. US dollar / HK dollar based investors are therefore exposed to fluctuations in the US dollar / HK dollar / base currency exchange rate.

BEFORE MAKING AN INVESTMENT, YOU SHOULD REFER TO THE RELEVANT OFFERING DOCUMENTS AND IN PARTICULAR TO THE INVESTMENT POLICIES AND THE RISK FACTORS. YOU SHOULD ENSURE THAT YOU FULLY UNDERSTAND THE RISKS ASSOCIATED WITH THE FUND AND SHOULD ALSO CONSIDER YOUR OWN INVESTMENT OBJECTIVE AND RISK TOLERANCE LEVEL. YOU ARE REMINDED THAT YOU ARE RESPONSIBLE FOR YOUR INVESTMENT DECISION AND SHOULD NOT INVEST UNLESS THE INTERMEDIARY WHO OFFERS OR SELLS THE FUND TO YOU HAS ADVISED THAT THE FUND IS SUITABLE FOR YOU AND HAS EXPLAINED WHY, INCLUDING HOW BUYING THE FUND WOULD BE CONSISTENT WITH YOUR INVESTMENT OBJECTIVE. IF IN DOUBT, PLEASE SEEK INDEPENDENT FINANCIAL AND PROFESSIONAL ADVICE.

The information and products contained within this website are restricted to investors within Hong Kong. There are important legal and regulatory restrictions which apply to this website. These are laid out in the Disclaimer section which you are advised to read before proceeding. By proceeding, you are representing that you have understood and accepted the restrictions set out in the Disclaimer section.

Third party websites provided by hyperlinks on this website are completely beyond the control of AASTOCKS. Accordingly, AASTOCKS accepts no responsibility for the accuracy, completeness and legality of the contents of such third party website, or for any offers, services and products contained therein.

Remarks: All HK and China Indices are real time. World indices are at least 30 – 60 minutes delayed.
 
 
 
ETF Comparison
1
2
Compare